The depth of mutational agony and the exuberance of tumoral T cell ecstasy predict checkpoint salvation.

Thomas V Guy, Shiv Pillai

Science Immunology 2018 December 8

Genomic biomarkers will help to elucidate which cancer patients will benefit from PD-1 blockade immunotherapy.

Full text links

We have located links that may give you full text access.

Show additional links to paperHide additional links to paper

Add to Saved Papers

Get 1-tap access

Related Resources

Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Fernando Ramasco et al.Journal of Personalized Medicine 2024 Februrary 4

Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.Alessio Mazzieri et al.International Journal of Molecular Sciences 2024 April 4

Perioperative echocardiographic strain analysis: what anesthesiologists should know.Adrian Costescu et al.Canadian Journal of Anaesthesia 2024 April 11

The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.Michael A Borger, Victoria DelgadoEuropean Heart Journal 2024 April 18

Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Simona Sacco et al.Diabetologia 2024 April 17

Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.Francisca Ferrer-Marín et al.British Journal of Haematology 2024 April 9

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app